Posts with tag akrx
Posted Apr 25th 2008 4:37PM by Eric Buscemi
Filed under: Earnings reports, Forecasts, Conventions and conferences, Annual meetings, Starbucks (SBUX), Exxon Mobil (XOM), Comcast Cl'A' (CMCSA), Verizon Communications (VZ), BP p.l.c. ADS (BP), Merck and Co (MRK), U.S. Steel (X), Genentech Inc (DNA), Tyson Foods'A' (TSN), Akamai Technologies (AKAM), Kraft Foods'A' (KFT)
.gif)
Monday, April 28
- PDUFA date for Genentech, Inc. (NYSE: DNA) and Roche Holding Ltd. (OTC: RHHBY)'s supplemental Biologics License Application for Herceptin for label expansion to include AC followed by docetaxel in treatment of adjuvant HER2+ breast cancer.
- PDUFA date for Shire plc (NASDAQ: SHPGY) and New River Pharma's supplemental New Drug Application for Vyvanse (NRP-104) treatment of Attention Deficit Hyperactivity Disordre, or ADHD, in adult patients 18-55 years old; the drug is already approved for pediatric ADHD ages 6-12.
- Verizon Communications Inc. (NYSE: VZ) to report Q earnings; conference call at 8:30am.
- Tyson Foods, Inc. (NYSE: TSN) to report Q2 earnings; conference call at 9:00am.
Tuesday, April 29
- Two-day FOMC meeting beginning at 8:30am.
- PDUFA date for Merck & Co., Inc. (NYSE: MRK)'s New Drug Application for Cordaptive (MK-0524A) adjunctive therapy to diet for treating elevated LDL Cholesterol, low HDL Cholesterol and elevated triglycerides levels.
- PDUFA date for Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP)'s supplemental New Drug Application for dose of 8mg treatment of Irritable Bowel Syndrome with Constipation; already approved for Chronic Idiopathic Constipation at 24ug dosage.
- BP plc (NYSE: BP) to report Q1 earnings; conference call at 10:15am.
- United States Steel Company (NYSE: X) to report Q1 earnings; conference call at 2:00pm.
Continue reading Market highlights for next week: Two-day FOMC meeting